| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Humans | 112 | 2023 | 4119 | 3.380 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 12 | 2022 | 13 | 3.070 |
Why?
|
| Mutation | 32 | 2022 | 608 | 2.610 |
Why?
|
| Pain Insensitivity, Congenital | 7 | 2022 | 7 | 2.160 |
Why?
|
| Membrane Proteins | 10 | 2023 | 101 | 1.920 |
Why?
|
| Female | 56 | 2022 | 2147 | 1.810 |
Why?
|
| High-Throughput Nucleotide Sequencing | 10 | 2023 | 173 | 1.770 |
Why?
|
| Endoplasmic Reticulum | 7 | 2023 | 22 | 1.610 |
Why?
|
| Phenotype | 19 | 2022 | 479 | 1.590 |
Why?
|
| Male | 49 | 2021 | 1811 | 1.500 |
Why?
|
| Channelopathies | 4 | 2022 | 8 | 1.460 |
Why?
|
| Animals | 40 | 2023 | 1545 | 1.360 |
Why?
|
| Genetic Variation | 3 | 2019 | 189 | 1.230 |
Why?
|
| Genetic Testing | 8 | 2021 | 66 | 1.220 |
Why?
|
| Peripheral Nervous System Diseases | 3 | 2022 | 10 | 1.140 |
Why?
|
| GTP Phosphohydrolases | 4 | 2019 | 11 | 1.140 |
Why?
|
| Mutation, Missense | 11 | 2021 | 124 | 1.090 |
Why?
|
| Axons | 4 | 2019 | 12 | 1.030 |
Why?
|
| Mice | 27 | 2023 | 737 | 1.020 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2020 | 529 | 1.000 |
Why?
|
| Cell Line | 11 | 2021 | 137 | 0.970 |
Why?
|
| Intellectual Disability | 6 | 2022 | 122 | 0.960 |
Why?
|
| Pedigree | 22 | 2022 | 304 | 0.950 |
Why?
|
| Genomics | 3 | 2023 | 143 | 0.920 |
Why?
|
| NAV1.9 Voltage-Gated Sodium Channel | 5 | 2020 | 6 | 0.900 |
Why?
|
| Neuromuscular Diseases | 1 | 2023 | 5 | 0.900 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2023 | 12 | 0.900 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2021 | 43 | 0.880 |
Why?
|
| Small Fiber Neuropathy | 2 | 2019 | 2 | 0.860 |
Why?
|
| Adult | 22 | 2022 | 944 | 0.820 |
Why?
|
| Chronic Pain | 1 | 2021 | 2 | 0.820 |
Why?
|
| Sodium Channels | 3 | 2019 | 5 | 0.810 |
Why?
|
| Kidney | 5 | 2022 | 38 | 0.780 |
Why?
|
| Cells | 1 | 2020 | 2 | 0.760 |
Why?
|
| Autophagy | 6 | 2023 | 20 | 0.760 |
Why?
|
| Limb Deformities, Congenital | 4 | 2021 | 18 | 0.730 |
Why?
|
| Child | 17 | 2022 | 557 | 0.730 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2019 | 1 | 0.690 |
Why?
|
| Neuralgia | 1 | 2019 | 7 | 0.680 |
Why?
|
| Silver-Russell Syndrome | 4 | 2020 | 39 | 0.680 |
Why?
|
| Neurons | 6 | 2021 | 78 | 0.680 |
Why?
|
| Internal Medicine | 1 | 2018 | 1 | 0.670 |
Why?
|
| Genetics, Medical | 1 | 2018 | 4 | 0.670 |
Why?
|
| Homozygote | 10 | 2023 | 117 | 0.660 |
Why?
|
| Pain | 6 | 2022 | 9 | 0.630 |
Why?
|
| Gene Duplication | 3 | 2016 | 24 | 0.610 |
Why?
|
| Alleles | 6 | 2022 | 221 | 0.600 |
Why?
|
| Spastic Paraplegia, Hereditary | 4 | 2022 | 13 | 0.590 |
Why?
|
| DNA Methylation | 5 | 2023 | 186 | 0.580 |
Why?
|
| Middle Aged | 15 | 2020 | 843 | 0.580 |
Why?
|
| Receptor, trkA | 1 | 2016 | 3 | 0.570 |
Why?
|
| Sodium | 2 | 2013 | 3 | 0.560 |
Why?
|
| Neoplasm Proteins | 3 | 2015 | 58 | 0.550 |
Why?
|
| Pain Threshold | 1 | 2015 | 1 | 0.540 |
Why?
|
| Voltage-Gated Sodium Channels | 1 | 2015 | 1 | 0.540 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 3 | 2020 | 5 | 0.540 |
Why?
|
| Developmental Disabilities | 3 | 2021 | 29 | 0.540 |
Why?
|
| Golgi Apparatus | 2 | 2019 | 6 | 0.530 |
Why?
|
| Membrane Transport Proteins | 4 | 2017 | 12 | 0.530 |
Why?
|
| Chloride-Bicarbonate Antiporters | 6 | 2013 | 6 | 0.520 |
Why?
|
| DNA, Intergenic | 2 | 2017 | 8 | 0.510 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 15 | 0.510 |
Why?
|
| Chromosomes, Human, Pair 11 | 4 | 2019 | 47 | 0.480 |
Why?
|
| Sequence Deletion | 6 | 2023 | 51 | 0.480 |
Why?
|
| Transcription Factors | 4 | 2022 | 256 | 0.470 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2013 | 4 | 0.460 |
Why?
|
| Signal Transduction | 7 | 2020 | 261 | 0.460 |
Why?
|
| Uniparental Disomy | 3 | 2017 | 19 | 0.450 |
Why?
|
| Loss of Function Mutation | 3 | 2021 | 29 | 0.450 |
Why?
|
| Adolescent | 14 | 2020 | 493 | 0.450 |
Why?
|
| Aged | 11 | 2020 | 580 | 0.440 |
Why?
|
| Polymorphism, Genetic | 5 | 2022 | 68 | 0.440 |
Why?
|
| Cysts | 2 | 2022 | 6 | 0.430 |
Why?
|
| Cells, Cultured | 6 | 2019 | 261 | 0.410 |
Why?
|
| Nociceptors | 5 | 2018 | 6 | 0.410 |
Why?
|
| Proteins | 3 | 2016 | 77 | 0.400 |
Why?
|
| Infant | 10 | 2021 | 267 | 0.400 |
Why?
|
| Membrane Glycoproteins | 5 | 2006 | 33 | 0.400 |
Why?
|
| DNA Copy Number Variations | 4 | 2021 | 79 | 0.400 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2022 | 16 | 0.400 |
Why?
|
| SOX9 Transcription Factor | 2 | 2016 | 2 | 0.390 |
Why?
|
| Microcephaly | 2 | 2021 | 65 | 0.390 |
Why?
|
| Carrier Proteins | 3 | 2017 | 65 | 0.390 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2022 | 8 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 12 | 2021 | 226 | 0.380 |
Why?
|
| Muscular Diseases | 2 | 2020 | 17 | 0.380 |
Why?
|
| Germ-Line Mutation | 2 | 2021 | 54 | 0.370 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2021 | 33 | 0.360 |
Why?
|
| Child, Preschool | 10 | 2020 | 378 | 0.360 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2009 | 14 | 0.360 |
Why?
|
| Nail Diseases | 1 | 2009 | 6 | 0.360 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2009 | 6 | 0.350 |
Why?
|
| Muscle Hypotonia | 2 | 2019 | 11 | 0.350 |
Why?
|
| Mice, Knockout | 8 | 2022 | 149 | 0.330 |
Why?
|
| Erythromelalgia | 3 | 2021 | 4 | 0.330 |
Why?
|
| Antigens, CD | 4 | 2000 | 48 | 0.320 |
Why?
|
| Heart Valve Diseases | 2 | 2018 | 5 | 0.320 |
Why?
|
| Aortic Valve | 2 | 2018 | 7 | 0.320 |
Why?
|
| Polyneuropathies | 2 | 2019 | 16 | 0.320 |
Why?
|
| Genes, Recessive | 3 | 2018 | 44 | 0.310 |
Why?
|
| Retinitis Pigmentosa | 2 | 2017 | 7 | 0.310 |
Why?
|
| Receptors, Virus | 2 | 2017 | 3 | 0.300 |
Why?
|
| Base Sequence | 7 | 2021 | 275 | 0.300 |
Why?
|
| Sensory Receptor Cells | 4 | 2023 | 6 | 0.300 |
Why?
|
| Stroke | 2 | 2017 | 17 | 0.300 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2021 | 37 | 0.300 |
Why?
|
| Interleukin-6 | 4 | 2000 | 43 | 0.290 |
Why?
|
| Young Adult | 8 | 2020 | 345 | 0.290 |
Why?
|
| Lysosomes | 3 | 2015 | 7 | 0.290 |
Why?
|
| Homeodomain Proteins | 2 | 2021 | 56 | 0.290 |
Why?
|
| Precision Medicine | 3 | 2021 | 22 | 0.290 |
Why?
|
| Hand Deformities, Congenital | 3 | 2017 | 25 | 0.290 |
Why?
|
| Cohort Studies | 7 | 2021 | 191 | 0.290 |
Why?
|
| Nerve Degeneration | 2 | 2016 | 8 | 0.280 |
Why?
|
| Genetic Association Studies | 4 | 2020 | 122 | 0.280 |
Why?
|
| Genotype | 5 | 2023 | 320 | 0.280 |
Why?
|
| HeLa Cells | 4 | 2019 | 62 | 0.280 |
Why?
|
| DNA Mutational Analysis | 4 | 2017 | 122 | 0.280 |
Why?
|
| Exons | 5 | 2022 | 97 | 0.270 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 74 | 0.270 |
Why?
|
| Syndrome | 3 | 2023 | 91 | 0.270 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 41 | 0.260 |
Why?
|
| Exome | 5 | 2016 | 124 | 0.260 |
Why?
|
| Muscle, Skeletal | 3 | 2020 | 73 | 0.260 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2019 | 16 | 0.250 |
Why?
|
| Pain Perception | 2 | 2015 | 4 | 0.250 |
Why?
|
| Genomic Imprinting | 3 | 2020 | 51 | 0.250 |
Why?
|
| Heterozygote | 7 | 2019 | 94 | 0.250 |
Why?
|
| Mitochondrial Proteins | 2 | 2021 | 35 | 0.240 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 2 | 2014 | 2 | 0.240 |
Why?
|
| NAV1.7 Voltage-Gated Sodium Channel | 2 | 2021 | 2 | 0.240 |
Why?
|
| Ubiquitinated Proteins | 1 | 2023 | 1 | 0.230 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2023 | 5 | 0.230 |
Why?
|
| Ubiquitination | 1 | 2023 | 7 | 0.230 |
Why?
|
| Eye Diseases, Hereditary | 2 | 2021 | 4 | 0.230 |
Why?
|
| Gain of Function Mutation | 2 | 2020 | 4 | 0.230 |
Why?
|
| Ketamine | 1 | 2023 | 2 | 0.230 |
Why?
|
| HMGB1 Protein | 1 | 2023 | 1 | 0.230 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 33 | 0.230 |
Why?
|
| Cell Nucleolus | 1 | 2023 | 2 | 0.230 |
Why?
|
| Mitochondria | 2 | 2021 | 150 | 0.220 |
Why?
|
| Protein Isoforms | 2 | 2019 | 37 | 0.220 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2022 | 4 | 0.220 |
Why?
|
| Varicose Veins | 1 | 2002 | 1 | 0.220 |
Why?
|
| Receptors, Peptide | 1 | 2022 | 1 | 0.220 |
Why?
|
| Cerebellar Diseases | 1 | 2022 | 4 | 0.220 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 26 | 0.220 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 13 | 0.220 |
Why?
|
| Schizophrenia | 1 | 2023 | 74 | 0.220 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 12 | 0.220 |
Why?
|
| Epitopes | 3 | 2000 | 22 | 0.220 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2022 | 25 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 99 | 0.210 |
Why?
|
| Codon, Nonsense | 2 | 2013 | 54 | 0.210 |
Why?
|
| Anus Neoplasms | 1 | 2022 | 1 | 0.210 |
Why?
|
| Self Mutilation | 1 | 2022 | 1 | 0.210 |
Why?
|
| Chemoradiotherapy | 1 | 2022 | 4 | 0.210 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 7 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 3 | 2019 | 249 | 0.210 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2000 | 3 | 0.210 |
Why?
|
| Membrane Potentials | 3 | 2021 | 21 | 0.210 |
Why?
|
| Myeloproliferative Disorders | 1 | 2021 | 9 | 0.210 |
Why?
|
| Abdominal Pain | 1 | 2021 | 2 | 0.200 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2021 | 1 | 0.200 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 14 | 0.200 |
Why?
|
| Glycogen | 1 | 2021 | 8 | 0.200 |
Why?
|
| Translocation, Genetic | 2 | 2012 | 41 | 0.200 |
Why?
|
| Brain | 4 | 2016 | 153 | 0.200 |
Why?
|
| Confidentiality | 1 | 2021 | 8 | 0.200 |
Why?
|
| Open Reading Frames | 1 | 2021 | 33 | 0.200 |
Why?
|
| Gene Expression | 5 | 2021 | 138 | 0.200 |
Why?
|
| Gene Expression Regulation | 5 | 2009 | 210 | 0.200 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 12 | 0.200 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2021 | 1 | 0.200 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 1 | 0.200 |
Why?
|
| Pulmonary Heart Disease | 1 | 2021 | 1 | 0.200 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2021 | 1 | 0.200 |
Why?
|
| Leukemia | 2 | 2021 | 37 | 0.200 |
Why?
|
| Huntington Disease | 1 | 2021 | 2 | 0.200 |
Why?
|
| Glaucoma | 1 | 2021 | 3 | 0.200 |
Why?
|
| COS Cells | 7 | 2018 | 18 | 0.200 |
Why?
|
| Datasets as Topic | 1 | 2021 | 16 | 0.200 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 9 | 0.200 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 15 | 0.200 |
Why?
|
| Cell Differentiation | 2 | 2021 | 199 | 0.200 |
Why?
|
| Machine Learning | 1 | 2021 | 27 | 0.200 |
Why?
|
| Fibroblasts | 5 | 2019 | 71 | 0.200 |
Why?
|
| Chromosome Deletion | 2 | 2019 | 45 | 0.200 |
Why?
|
| Neprilysin | 1 | 2020 | 2 | 0.200 |
Why?
|
| Pruritus | 1 | 2020 | 2 | 0.190 |
Why?
|
| Language Development Disorders | 1 | 2020 | 3 | 0.190 |
Why?
|
| Muscle Weakness | 1 | 2020 | 5 | 0.190 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2020 | 1 | 0.190 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2020 | 14 | 0.190 |
Why?
|
| Autistic Disorder | 1 | 2020 | 12 | 0.190 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2020 | 1 | 0.190 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 17 | 0.190 |
Why?
|
| Endocrine System Diseases | 1 | 2020 | 2 | 0.190 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2020 | 18 | 0.190 |
Why?
|
| Genome-Wide Association Study | 5 | 2023 | 417 | 0.190 |
Why?
|
| Introns | 2 | 2019 | 60 | 0.180 |
Why?
|
| Spectrin | 1 | 2019 | 3 | 0.180 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2019 | 1 | 0.180 |
Why?
|
| Fixation, Ocular | 1 | 2019 | 1 | 0.180 |
Why?
|
| Ocular Motility Disorders | 1 | 2019 | 3 | 0.180 |
Why?
|
| Gene Dosage | 2 | 2017 | 17 | 0.180 |
Why?
|
| Kallmann Syndrome | 2 | 2010 | 2 | 0.180 |
Why?
|
| DNA | 2 | 2017 | 102 | 0.180 |
Why?
|
| DNA Repeat Expansion | 1 | 2019 | 2 | 0.180 |
Why?
|
| Esophageal Achalasia | 2 | 2017 | 5 | 0.180 |
Why?
|
| Hypogonadism | 2 | 2010 | 6 | 0.180 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2019 | 7 | 0.180 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2019 | 3 | 0.180 |
Why?
|
| Point Mutation | 2 | 2018 | 36 | 0.180 |
Why?
|
| Hepatitis C, Chronic | 1 | 2019 | 3 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2023 | 50 | 0.180 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2019 | 7 | 0.180 |
Why?
|
| Medulloblastoma | 1 | 2019 | 18 | 0.180 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2019 | 4 | 0.180 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 9 | 0.180 |
Why?
|
| Osteochondrodysplasias | 1 | 2019 | 12 | 0.180 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 26 | 0.180 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 31 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 14 | 0.180 |
Why?
|
| Consanguinity | 5 | 2019 | 56 | 0.180 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 18 | 0.180 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2019 | 3 | 0.180 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2019 | 4 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2019 | 20 | 0.170 |
Why?
|
| Sodium-Bicarbonate Symporters | 2 | 2010 | 2 | 0.170 |
Why?
|
| Benserazide | 1 | 2019 | 2 | 0.170 |
Why?
|
| Hyperkinesis | 1 | 2019 | 2 | 0.170 |
Why?
|
| Levodopa | 1 | 2019 | 2 | 0.170 |
Why?
|
| Aromatic Amino Acid Decarboxylase Inhibitors | 1 | 2019 | 2 | 0.170 |
Why?
|
| Dopamine Agents | 1 | 2019 | 3 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2019 | 4 | 0.170 |
Why?
|
| Sepsis | 1 | 2019 | 6 | 0.170 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 99 | 0.170 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2019 | 4 | 0.170 |
Why?
|
| Autophagosomes | 1 | 2019 | 1 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 3 | 0.170 |
Why?
|
| Fatty Acid Desaturases | 1 | 2019 | 5 | 0.170 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2019 | 5 | 0.170 |
Why?
|
| Sphingosine | 1 | 2019 | 8 | 0.170 |
Why?
|
| GTP-Binding Proteins | 1 | 2019 | 5 | 0.170 |
Why?
|
| Aging | 1 | 2020 | 92 | 0.170 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2019 | 21 | 0.170 |
Why?
|
| Dystonin | 1 | 2018 | 1 | 0.170 |
Why?
|
| Actin Cytoskeleton | 1 | 2018 | 1 | 0.170 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2018 | 3 | 0.170 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2018 | 3 | 0.170 |
Why?
|
| Hypokinesia | 1 | 2018 | 4 | 0.170 |
Why?
|
| Cystine | 1 | 2018 | 1 | 0.170 |
Why?
|
| Cystinuria | 1 | 2018 | 1 | 0.170 |
Why?
|
| Amino Acid Transport Systems | 1 | 2018 | 2 | 0.170 |
Why?
|
| Protein Binding | 6 | 2018 | 97 | 0.170 |
Why?
|
| Amino Acid Substitution | 2 | 2019 | 45 | 0.170 |
Why?
|
| Muscular Atrophy | 1 | 2018 | 2 | 0.170 |
Why?
|
| Maternal Inheritance | 1 | 2018 | 9 | 0.170 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2018 | 2 | 0.170 |
Why?
|
| Ion Channels | 1 | 2018 | 7 | 0.170 |
Why?
|
| Mullerian Ducts | 1 | 2018 | 2 | 0.170 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2018 | 2 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 39 | 0.170 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 9 | 0.170 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 6 | 0.170 |
Why?
|
| Molecular Biology | 1 | 2018 | 6 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 23 | 0.170 |
Why?
|
| Oxidative Stress | 2 | 2016 | 50 | 0.160 |
Why?
|
| Receptors, Cytokine | 2 | 2017 | 5 | 0.160 |
Why?
|
| Dyskeratosis Congenita | 1 | 2018 | 4 | 0.160 |
Why?
|
| Retinal Dehydrogenase | 2 | 2009 | 5 | 0.160 |
Why?
|
| Telomere Shortening | 1 | 2018 | 7 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2022 | 120 | 0.160 |
Why?
|
| Germany | 3 | 2018 | 251 | 0.160 |
Why?
|
| Placenta | 1 | 2017 | 5 | 0.160 |
Why?
|
| Trisomy | 1 | 2017 | 6 | 0.160 |
Why?
|
| Germ Cells | 3 | 2023 | 30 | 0.160 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 78 | 0.160 |
Why?
|
| Cell Membrane | 3 | 2013 | 20 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2017 | 25 | 0.160 |
Why?
|
| Ataxia | 1 | 2017 | 7 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2018 | 82 | 0.160 |
Why?
|
| Forecasting | 1 | 2017 | 3 | 0.150 |
Why?
|
| Ciliary Motility Disorders | 1 | 2017 | 2 | 0.150 |
Why?
|
| Encephalocele | 1 | 2017 | 2 | 0.150 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2017 | 4 | 0.150 |
Why?
|
| Fetal Diseases | 1 | 2017 | 7 | 0.150 |
Why?
|
| Gene Library | 1 | 2017 | 20 | 0.150 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2017 | 1 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2017 | 25 | 0.150 |
Why?
|
| Hyperhidrosis | 1 | 2017 | 1 | 0.150 |
Why?
|
| Trismus | 1 | 2017 | 1 | 0.150 |
Why?
|
| Age of Onset | 4 | 2020 | 40 | 0.150 |
Why?
|
| Social Support | 1 | 2017 | 1 | 0.150 |
Why?
|
| Sex Reassignment Procedures | 1 | 2017 | 1 | 0.150 |
Why?
|
| Transgender Persons | 1 | 2017 | 1 | 0.150 |
Why?
|
| Sexism | 1 | 2017 | 1 | 0.150 |
Why?
|
| Adenosine Deaminase | 1 | 2016 | 1 | 0.150 |
Why?
|
| Motor Neurons | 2 | 2013 | 5 | 0.150 |
Why?
|
| Brain Ischemia | 1 | 2016 | 4 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 148 | 0.150 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2016 | 3 | 0.150 |
Why?
|
| Disease | 1 | 2016 | 6 | 0.150 |
Why?
|
| Myelin Proteins | 1 | 2016 | 2 | 0.150 |
Why?
|
| Munc18 Proteins | 1 | 2016 | 2 | 0.150 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 20 | 0.150 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 139 | 0.140 |
Why?
|
| Amelogenesis Imperfecta | 1 | 2016 | 1 | 0.140 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 86 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 15 | 0.140 |
Why?
|
| Frameshift Mutation | 3 | 2023 | 32 | 0.140 |
Why?
|
| Epilepsy | 1 | 2016 | 53 | 0.140 |
Why?
|
| Infant, Newborn | 4 | 2018 | 119 | 0.140 |
Why?
|
| Ions | 2 | 2013 | 10 | 0.140 |
Why?
|
| Mice, Transgenic | 5 | 2017 | 111 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 103 | 0.130 |
Why?
|
| Ectromelia | 2 | 2012 | 2 | 0.130 |
Why?
|
| Tibia | 2 | 2012 | 4 | 0.130 |
Why?
|
| Inflammation | 1 | 2016 | 179 | 0.130 |
Why?
|
| Nerve Net | 1 | 2014 | 2 | 0.130 |
Why?
|
| Lipid Bilayers | 1 | 2014 | 4 | 0.130 |
Why?
|
| Prognosis | 3 | 2022 | 196 | 0.130 |
Why?
|
| Osteopetrosis | 1 | 2014 | 1 | 0.120 |
Why?
|
| Calcification, Physiologic | 1 | 2014 | 4 | 0.120 |
Why?
|
| Chloride Channels | 1 | 2014 | 4 | 0.120 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2014 | 3 | 0.120 |
Why?
|
| Adherens Junctions | 1 | 2014 | 2 | 0.120 |
Why?
|
| Amino Acid Sequence | 4 | 2018 | 186 | 0.120 |
Why?
|
| Calcium | 3 | 2021 | 42 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 143 | 0.120 |
Why?
|
| Bone Diseases | 1 | 2014 | 1 | 0.120 |
Why?
|
| Syndactyly | 1 | 2014 | 13 | 0.120 |
Why?
|
| Facies | 3 | 2020 | 40 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 20 | 0.120 |
Why?
|
| Ectodermal Dysplasia | 1 | 2014 | 12 | 0.120 |
Why?
|
| Retinal Degeneration | 1 | 2013 | 9 | 0.120 |
Why?
|
| Guanosine Diphosphate Mannose | 1 | 2013 | 2 | 0.120 |
Why?
|
| Nucleotidyltransferases | 1 | 2013 | 8 | 0.120 |
Why?
|
| Endosomes | 1 | 2013 | 23 | 0.120 |
Why?
|
| Absorption | 1 | 2013 | 1 | 0.120 |
Why?
|
| Perfusion | 1 | 2013 | 2 | 0.120 |
Why?
|
| Proton Pumps | 1 | 2013 | 2 | 0.120 |
Why?
|
| Sodium Chloride | 1 | 2013 | 9 | 0.120 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 206 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2012 | 95 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 11 | 0.110 |
Why?
|
| Chromosome Disorders | 1 | 2012 | 9 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2023 | 18 | 0.110 |
Why?
|
| Craniofacial Abnormalities | 1 | 2012 | 21 | 0.110 |
Why?
|
| Haplotypes | 3 | 2022 | 122 | 0.110 |
Why?
|
| Paired Box Transcription Factors | 1 | 2012 | 2 | 0.110 |
Why?
|
| Lower Extremity | 1 | 2012 | 4 | 0.110 |
Why?
|
| Polydactyly | 1 | 2012 | 3 | 0.110 |
Why?
|
| Inheritance Patterns | 1 | 2011 | 10 | 0.110 |
Why?
|
| Biomarkers | 3 | 2018 | 188 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 19 | 0.100 |
Why?
|
| Hearing Loss | 1 | 2011 | 5 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2011 | 11 | 0.100 |
Why?
|
| Chromosomes, Human, X | 1 | 2011 | 15 | 0.100 |
Why?
|
| Puberty | 1 | 2010 | 5 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2010 | 15 | 0.100 |
Why?
|
| Gene Frequency | 2 | 2022 | 120 | 0.100 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2010 | 1 | 0.090 |
Why?
|
| HEK293 Cells | 2 | 2021 | 64 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2009 | 263 | 0.090 |
Why?
|
| Gene Targeting | 2 | 2006 | 13 | 0.090 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2009 | 1 | 0.090 |
Why?
|
| RNA Interference | 1 | 2009 | 48 | 0.090 |
Why?
|
| Siblings | 2 | 2019 | 28 | 0.090 |
Why?
|
| Genes, APC | 1 | 2009 | 4 | 0.090 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2009 | 7 | 0.090 |
Why?
|
| DNA Helicases | 1 | 2008 | 17 | 0.080 |
Why?
|
| Cytokine Receptor gp130 | 4 | 2000 | 8 | 0.080 |
Why?
|
| Models, Biological | 3 | 2018 | 115 | 0.080 |
Why?
|
| Transfection | 3 | 2009 | 51 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2013 | 301 | 0.080 |
Why?
|
| Haploinsufficiency | 2 | 2022 | 15 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2008 | 40 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2021 | 322 | 0.080 |
Why?
|
| Cerebrospinal Fluid | 1 | 2007 | 6 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2017 | 552 | 0.080 |
Why?
|
| Action Potentials | 2 | 2021 | 9 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 65 | 0.080 |
Why?
|
| Zebrafish | 3 | 2012 | 57 | 0.080 |
Why?
|
| Pregnancy | 2 | 2017 | 113 | 0.080 |
Why?
|
| Vision, Ocular | 1 | 2006 | 4 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2006 | 2 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2018 | 15 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 5 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2006 | 115 | 0.070 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2006 | 1 | 0.070 |
Why?
|
| Thrombophlebitis | 1 | 2006 | 1 | 0.070 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 1 | 0.070 |
Why?
|
| Convulsants | 1 | 2006 | 1 | 0.070 |
Why?
|
| Antiporters | 1 | 2006 | 3 | 0.070 |
Why?
|
| Seizures | 1 | 2006 | 24 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2006 | 35 | 0.070 |
Why?
|
| Apoptosis | 2 | 2016 | 94 | 0.070 |
Why?
|
| Protein Transport | 2 | 2020 | 31 | 0.070 |
Why?
|
| Fingers | 2 | 2016 | 13 | 0.060 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 14 | 0.060 |
Why?
|
| Dimerization | 2 | 2000 | 2 | 0.060 |
Why?
|
| Solubility | 2 | 2000 | 7 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2023 | 10 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2023 | 5 | 0.060 |
Why?
|
| Midazolam | 1 | 2023 | 2 | 0.060 |
Why?
|
| Phase Transition | 1 | 2023 | 2 | 0.060 |
Why?
|
| Arginine | 1 | 2023 | 4 | 0.060 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2023 | 2 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2023 | 22 | 0.060 |
Why?
|
| Antibodies | 1 | 2022 | 11 | 0.060 |
Why?
|
| TRPP Cation Channels | 1 | 2022 | 3 | 0.060 |
Why?
|
| CD24 Antigen | 1 | 2022 | 5 | 0.060 |
Why?
|
| Organoids | 1 | 2022 | 7 | 0.060 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2002 | 1 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 1 | 0.060 |
Why?
|
| Paraplegia | 1 | 2022 | 2 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 27 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2002 | 14 | 0.060 |
Why?
|
| Interleukin-11 | 2 | 2000 | 4 | 0.050 |
Why?
|
| Endrin | 1 | 2022 | 1 | 0.050 |
Why?
|
| Mitomycin | 1 | 2022 | 3 | 0.050 |
Why?
|
| HIV Infections | 1 | 2022 | 11 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 1 | 2021 | 5 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2015 | 57 | 0.050 |
Why?
|
| Janus Kinase 2 | 1 | 2021 | 7 | 0.050 |
Why?
|
| BRCA1 Protein | 1 | 2021 | 19 | 0.050 |
Why?
|
| Ribonuclease III | 1 | 2021 | 9 | 0.050 |
Why?
|
| Glycogen Debranching Enzyme System | 1 | 2021 | 6 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 13 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2021 | 12 | 0.050 |
Why?
|
| Leukocytes | 1 | 2021 | 22 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2021 | 14 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 27 | 0.050 |
Why?
|
| Voltage-Gated Sodium Channel beta-4 Subunit | 1 | 2021 | 1 | 0.050 |
Why?
|
| Pulmonary Veins | 1 | 2021 | 1 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2021 | 8 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2000 | 1 | 0.050 |
Why?
|
| Ligands | 1 | 2000 | 10 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2000 | 11 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2000 | 8 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 14 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2000 | 16 | 0.050 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2020 | 6 | 0.050 |
Why?
|
| DNA Repair | 1 | 2021 | 60 | 0.050 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2020 | 1 | 0.050 |
Why?
|
| Hand Strength | 1 | 2020 | 1 | 0.050 |
Why?
|
| Gastrointestinal Transit | 1 | 2020 | 2 | 0.050 |
Why?
|
| Movement | 1 | 2020 | 4 | 0.050 |
Why?
|
| Sciatic Nerve | 1 | 2020 | 2 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2020 | 5 | 0.050 |
Why?
|
| Vacuoles | 1 | 2020 | 7 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2020 | 9 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2000 | 4 | 0.050 |
Why?
|
| Acetazolamide | 1 | 2019 | 1 | 0.050 |
Why?
|
| Thiazines | 1 | 2019 | 1 | 0.050 |
Why?
|
| Peptides | 1 | 2000 | 38 | 0.050 |
Why?
|
| Hedgehog Proteins | 1 | 2019 | 13 | 0.040 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2019 | 1 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2019 | 5 | 0.040 |
Why?
|
| Body Weight | 1 | 2019 | 13 | 0.040 |
Why?
|
| Body Height | 1 | 2019 | 11 | 0.040 |
Why?
|
| Software | 1 | 2021 | 133 | 0.040 |
Why?
|
| Wallerian Degeneration | 1 | 2019 | 2 | 0.040 |
Why?
|
| Fetal Development | 1 | 2019 | 2 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 34 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 64 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2019 | 174 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2019 | 4 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2019 | 7 | 0.040 |
Why?
|
| Liver | 1 | 2019 | 61 | 0.040 |
Why?
|
| Interleukin-7 | 1 | 2019 | 5 | 0.040 |
Why?
|
| Antigens, Fungal | 1 | 2019 | 4 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2019 | 11 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2018 | 2 | 0.040 |
Why?
|
| Dermis | 1 | 2018 | 3 | 0.040 |
Why?
|
| Contracture | 1 | 2018 | 3 | 0.040 |
Why?
|
| Actins | 1 | 2018 | 13 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 146 | 0.040 |
Why?
|
| Family | 1 | 2018 | 36 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 39 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2019 | 41 | 0.040 |
Why?
|
| Cell Movement | 1 | 2018 | 45 | 0.040 |
Why?
|
| Autoantigens | 1 | 2018 | 12 | 0.040 |
Why?
|
| Preliminary Data | 1 | 2018 | 1 | 0.040 |
Why?
|
| Guanosine Triphosphate | 1 | 2018 | 2 | 0.040 |
Why?
|
| Membrane Fusion | 1 | 2018 | 2 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2018 | 3 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2018 | 4 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2018 | 10 | 0.040 |
Why?
|
| Retinoids | 2 | 2009 | 2 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2009 | 6 | 0.040 |
Why?
|
| Biopsy | 1 | 2018 | 31 | 0.040 |
Why?
|
| Incidence | 1 | 2018 | 54 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 83 | 0.040 |
Why?
|
| Steroid 21-Hydroxylase | 1 | 2017 | 2 | 0.040 |
Why?
|
| Karyotype | 1 | 2017 | 11 | 0.040 |
Why?
|
| Cullin Proteins | 1 | 2017 | 4 | 0.040 |
Why?
|
| Premature Birth | 1 | 2017 | 8 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 2017 | 15 | 0.040 |
Why?
|
| Mosaicism | 1 | 2017 | 9 | 0.040 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2017 | 4 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 2 | 0.040 |
Why?
|
| Abortion, Induced | 1 | 2017 | 3 | 0.040 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2017 | 6 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 7 | 0.040 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 1 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2017 | 1 | 0.040 |
Why?
|
| Vasculitis | 1 | 2017 | 2 | 0.040 |
Why?
|
| Karyotyping | 1 | 2017 | 28 | 0.040 |
Why?
|
| Echocardiography | 1 | 2017 | 14 | 0.040 |
Why?
|
| Muscles | 1 | 2017 | 11 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2017 | 17 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2017 | 24 | 0.040 |
Why?
|
| Death, Sudden | 1 | 2017 | 1 | 0.040 |
Why?
|
| Protein Domains | 1 | 2017 | 6 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 10 | 0.040 |
Why?
|
| Genome, Human | 1 | 2017 | 104 | 0.040 |
Why?
|
| Age Distribution | 1 | 2017 | 5 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2017 | 5 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2007 | 14 | 0.040 |
Why?
|
| Leg | 1 | 2016 | 1 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 31 | 0.040 |
Why?
|
| Hand | 1 | 2016 | 4 | 0.040 |
Why?
|
| Heme | 1 | 2016 | 3 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2016 | 11 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 138 | 0.040 |
Why?
|
| Foot Deformities, Congenital | 1 | 2016 | 8 | 0.040 |
Why?
|
| Netherlands | 1 | 2016 | 25 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 21 | 0.040 |
Why?
|
| Dental Enamel | 1 | 2016 | 1 | 0.040 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2016 | 5 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2015 | 5 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2015 | 4 | 0.030 |
Why?
|
| Motor Cortex | 1 | 2015 | 3 | 0.030 |
Why?
|
| Cerebellum | 1 | 2015 | 16 | 0.030 |
Why?
|
| Phagosomes | 1 | 2015 | 1 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2015 | 10 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 13 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2015 | 19 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 18 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 51 | 0.030 |
Why?
|
| Nectins | 1 | 2014 | 1 | 0.030 |
Why?
|
| Cell Aggregation | 1 | 2014 | 3 | 0.030 |
Why?
|
| Dogs | 1 | 2014 | 4 | 0.030 |
Why?
|
| Cough | 1 | 2014 | 1 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 1 | 0.030 |
Why?
|
| Fractures, Bone | 1 | 2014 | 2 | 0.030 |
Why?
|
| Kinetics | 1 | 2014 | 43 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 1 | 2014 | 3 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2014 | 17 | 0.030 |
Why?
|
| Corpus Callosum | 1 | 2013 | 6 | 0.030 |
Why?
|
| Homeostasis | 1 | 2014 | 50 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 4 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 6 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 4 | 0.030 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2013 | 2 | 0.030 |
Why?
|
| Adrenal Insufficiency | 1 | 2013 | 3 | 0.030 |
Why?
|
| Glycosylation | 1 | 2013 | 4 | 0.030 |
Why?
|
| Gait | 1 | 2013 | 4 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2013 | 12 | 0.030 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2012 | 1 | 0.030 |
Why?
|
| NAV1.3 Voltage-Gated Sodium Channel | 1 | 2012 | 1 | 0.030 |
Why?
|
| Clubfoot | 1 | 2012 | 2 | 0.030 |
Why?
|
| Bone Diseases, Developmental | 1 | 2012 | 5 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 32 | 0.030 |
Why?
|
| Cochlea | 1 | 2011 | 4 | 0.030 |
Why?
|
| Hair Cells, Auditory | 1 | 2011 | 4 | 0.030 |
Why?
|
| Ear, Inner | 1 | 2011 | 6 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2011 | 46 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 14 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2010 | 13 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 14 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2010 | 34 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 42 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 93 | 0.020 |
Why?
|
| Rats | 1 | 2010 | 164 | 0.020 |
Why?
|
| Amiloride | 1 | 2010 | 1 | 0.020 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2010 | 1 | 0.020 |
Why?
|
| Hydrochlorothiazide | 1 | 2010 | 2 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2010 | 3 | 0.020 |
Why?
|
| Xenopus | 1 | 2010 | 5 | 0.020 |
Why?
|
| Oocytes | 1 | 2010 | 14 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2009 | 1 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2000 | 50 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 21 | 0.020 |
Why?
|
| Binding Sites | 2 | 2000 | 73 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2009 | 13 | 0.020 |
Why?
|
| Retina | 1 | 2009 | 26 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2008 | 4 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 45 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 133 | 0.020 |
Why?
|
| Chromatin | 1 | 2008 | 49 | 0.020 |
Why?
|
| Learning | 1 | 2007 | 4 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2007 | 13 | 0.020 |
Why?
|
| Biological Transport | 1 | 2007 | 30 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2006 | 3 | 0.020 |
Why?
|
| Electroretinography | 1 | 2006 | 3 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2007 | 117 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 6, Group A, Member 1 | 1 | 2006 | 1 | 0.020 |
Why?
|
| Pseudogenes | 1 | 2006 | 2 | 0.020 |
Why?
|
| Tretinoin | 1 | 2006 | 2 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2006 | 15 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2006 | 83 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 2 | 0.020 |
Why?
|
| Acute Disease | 1 | 2006 | 17 | 0.020 |
Why?
|
| Bicuculline | 1 | 2006 | 1 | 0.020 |
Why?
|
| Sensory Thresholds | 1 | 2006 | 1 | 0.020 |
Why?
|
| Pentylenetetrazole | 1 | 2006 | 2 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2006 | 2 | 0.020 |
Why?
|
| Pilocarpine | 1 | 2006 | 6 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2006 | 9 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 43 | 0.020 |
Why?
|
| Risk Factors | 1 | 2006 | 265 | 0.020 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2000 | 1 | 0.010 |
Why?
|
| Receptors, OSM-LIF | 1 | 2000 | 1 | 0.010 |
Why?
|
| Receptors, Oncostatin M | 1 | 2000 | 1 | 0.010 |
Why?
|
| Oncostatin M | 1 | 2000 | 1 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2000 | 2 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2000 | 3 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2000 | 7 | 0.010 |
Why?
|
| Lymphokines | 1 | 2000 | 3 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 21 | 0.010 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2000 | 1 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 2000 | 4 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 21 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2000 | 26 | 0.010 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 1999 | 1 | 0.010 |
Why?
|
| Receptors, Interleukin-11 | 1 | 1999 | 3 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 3 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 1999 | 4 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1999 | 30 | 0.010 |
Why?
|
